Escherichia coli Nissle

Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., Schroder, J. M., and Stange, E. F. (2004). NF-kB- and AP-l-mediated induction of human p-defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917 A novel effect of a probiotic bacterium. Infect. Immun. 72(10), 5750-5758. 

Zyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., and Schmidt, M. A. (2007). Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9(3), 804-816. 

Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C., and Schulze, J. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53(11), 1617-1623. 

Infection unrelated to product contamination BaciUe Cafinette-Guerin [91-93] Escherichia coli Nissle 1917 [94] lactohacillus [95,96] mumps vaccine [97] varicella vaccine [98-100] Polymerase chain reaction, DNA enzyme immunoassay electrophoresis, bacterial culture, strain typing, DNA fingerprinting genomic sequencing... 

Zhou, S., Zhang, M., Wang, J., 2011. Tumor-targeted dehvery of TAT-Apoptin fusion gene using Escherichia coli Nissle 1917 to colorectal cancer. Med. Hypotheses 76, 533-534. 

Altenhoefer, A., Oswald, S., Sonnenborn, U., Enders, C., Schulze, J., Hacker, J., and Oelschlaeger, T. A. (2004). The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 40, 223-229. 

---